PS0	O
Germline	O
(	O
present	O
in	O
every	O
cell	O
of	O
the	O
body	O
)	O
mutations	O
in	O
RET-13	BG
cause	O
multiple	O
endocrine	O
neoplasia-17	BP
type	O
2	O
,	O
an	O
inherited	O
cancer-23	BP
syndrome	O
characterized	O
by	O
medullary	O
thyroid	BP
carcinoma-29	IP
,	O
pheochromocytoma-31	BP
,	O
and	O
hyperparathyroidism-34	BP
.	O

PS15	O
The	O
frequency	O
of	O
pes	O
cavus	O
,	O
scoliosis-7	BP
,	O
axonal	O
sensory	O
neuropathy-11	BP
and	O
areflexia-13	BP
increased	O
with	O
the	O
size	O
of	O
GAA1-19	BG
,	O
whereas	O
some	O
signs	O
such	O
as	O
sphincter	BP
disturbances-27	IP
,	O
cerebellar	O
atrophy	O
on	O
MRI	O
,	O
amyotrophy-34	BP
,	O
dysarthria-36	BP
and	O
decreased	O
vibration	O
sense	O
were	O
associated	O
with	O
increased	O
duration	O
of	O
the	O
disease	O
.	O

PS42	O
Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
early	O
onset	O
neuropathy-10	BP
is	O
caused	O
by	O
Myelin	BG
protein	IG
zero	IG
mutations	IG
that	O
significantly	O
disrupt	O
the	O
tertiary	O
structure	O
of	O
Myelin	BG
protein	IG
zero-27	IG
and	O
thus	O
interfere	O
with	O
Myelin	BG
protein-33	IG
zero	O
-	O
mediated	O
adhesion	O
and	O
myelin	O
compaction	O
.	O

PS95	O
We	O
recently	O
described	O
a	O
homozygous	O
frameshift	O
mutation	O
in	O
the	O
human	BG
leptin-11	IG
(	IG
ob-13	IG
)	IG
gene	IG
associated	O
with	O
undetectable	BP
serum	IP
leptin-20	IP
and	O
extreme	O
obesity-23	BP
in	O
two	O
individuals	O
.	O

PS98	O
Partial	BG
deletions	IG
of	IG
Hsa21-4	IG
were	O
identified	O
in	O
three	O
patients	O
with	O
developmental	BP
delay-12	IP
,	O
epilepsy-14	BP
,	O
microcephaly-16	BP
,	O
and	O
distinctive	O
manifestations	O
.	O

PS104	O
Mutations	O
in	O
the	O
SLC22A12	BG
gene-5	IG
,	O
which	O
encodes	O
a	O
uric	O
acid	O
transporter	O
,	O
URAT1	O
,	O
are	O
associated	O
with	O
renal	BP
hypouricaemia-20	IP
.	O

PS111	O
Presence	O
of	O
a	O
CRP4	BG
A	IG
-	IG
allele-7	IG
was	O
associated	O
with	O
systemic	BP
lupus	IP
erythematosus	IP
nephritis-14	IP
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
inversely	O
correlated	O
with	O
arthritis-26	BP
(	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
when	O
comparing	O
within	O
the	O
systemic	O
lupus	O
erythematosus	O
group	O
.	O

PS143	O
Higher	O
Insulin	BG
-	IG
like	IG
growth	IG
factor	IG
1-7	IG
circulating	O
levels	O
significantly	O
increased	O
15	O
%	O
of	O
cancer-15	BP
risk	O
(	O
odds	O
ratio	O
(	O
OR	O
)	O
,	O
1	O
.	O
15	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
,	O
1	O
.	O
03	O
-	O
1	O
.	O
29	O
)	O
,	O
especially	O
among	O
prostate	BP
,	O
pre	BP
-	IP
menopausal	IP
breast-52	IP
and	O
colorectal	BP
cancer-55	IP
patients	O
,	O
whereas	O
higher	O
concentrations	O
of	O
IGF	BG
-	IG
binding	IG
protein	IG
3-66	IG
significantly	O
decreased	O
the	O
risk	O
of	O
advanced	O
prostate	BP
cancer-74	IP
by	O
56	O
%	O
(	O
OR	O
,	O
0	O
.	O
44	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
25	O
-	O
0	O
.	O
77	O
)	O
.	O

PS195	O
The	O
study	O
was	O
designed	O
to	O
examine	O
the	O
effect	O
on	O
clinical	O
expression	O
of	O
rheumatoid	BP
arthritis-14	IP
of	O
HLA	BG
alleles-17	IG
,	O
particularly	O
DR4-20	BG
and	O
DR1-22	BG
that	O
contain	O
susceptibility	O
sequences	O
for	O
rheumatoid	BP
arthritis-29	IP
in	O
the	O
third	O
hypervariable	O
region	O
(	O
HVR3-36	BG
)	O
of	O
HLA	BG
-	IG
DRB1-41	IG
.	O

PS217	O
The	O
genetic	O
control	O
of	O
sex	O
and	O
HLA	BG
-	IG
B8-9	IG
,	O
DR3-11	BG
of	O
serum	BG
IgA-14	IG
levels	O
could	O
be	O
related	O
to	O
the	O
high	O
incidence	O
of	O
autoimmune	BP
disorders-25	IP
among	O
females	O
and	O
HLA	BG
-	IG
B8-31	IG
,	O
DR3-33	BG
-	O
positive	O
individuals	O
.	O

PS232	O
Congenital	BP
hyperinsulinism-2	IP
is	O
characterized	O
by	O
persistent	O
hypoglycemia-7	BP
due	O
to	O
the	O
inappropriate	O
insulin-12	BG
secretion	O
.	O

PS266	O
The	O
RET	BG
proto	IG
-	IG
oncogene-5	IG
is	O
responsible	O
for	O
medullary	O
thyroid	BP
cancer-11	IP
and	O
multiple	O
endocrine	O
neoplasia-15	BP
type	O
2	O
.	O

PS271	O
Frequent	O
inactivation	O
of	O
DMBT1-4	BG
contrasting	O
with	O
rare	O
mutations	O
of	O
PTEN-10	BG
may	O
indicate	O
that	O
DMBT1-14	BG
is	O
preferentially	O
involved	O
in	O
oligodendrogliomas-19	BP
.	O

PS321	O
Loss	BG
-	IG
of	IG
-	IG
function	IG
mutations	IG
of	IG
the	IG
MECP2	IG
gene	IG
at	IG
Xq28-12	IG
are	O
associated	O
with	O
Rett	O
syndrome	O
in	O
females	O
and	O
with	O
syndromic	O
and	O
nonsyndromic	O
forms	O
of	O
mental	BP
retardation-28	IP
in	O
males	O
.	O

PS324	O
Anhidrotic	BP
ectodermal	IP
dysplasia-3	IP
is	O
caused	O
by	O
mutations	O
in	O
the	O
ectodermal	BP
dysplasia-11	IP
gene	O
encoding	O
ectodysplasin	BG
A-15	IG
,	O
a	O
member	O
of	O
the	O
TNF	BG
ligand	IG
superfamily-23	IG
involved	O
in	O
the	O
communication	O
between	O
the	O
cells	O
.	O

PS328	O
Mutation	O
screening	O
and	O
analysis	O
in	O
hypertrophic	O
cardiomyopathy-7	BP
family	O
could	O
therefore	O
facilitate	O
the	O
early	O
hypertrophic	O
cardiomyopathy	O
diagnosis	O
and	O
would	O
be	O
helpful	O
for	O
the	O
prediction	O
,	O
prevention	O
and	O
early	O
treatment	O
of	O
hypertrophic	BP
cardiomyopathy-31	IP
linked	O
with	O
MYH7	BG
gene-35	IG
mutation	O
.	O

PS368	O
Unlike	O
mutations	BG
in	IG
the	IG
beta	IG
-	IG
myosin	IG
heavy	IG
chain	IG
gene-10	IG
,	O
the	O
prognostic	O
significance	O
of	O
which	O
reflect	O
their	O
hypertrophic	O
expressivity	O
,	O
cardiac	O
troponinT	BG
mutations	IG
are	O
associated	O
with	O
a	O
mild	O
degree	O
of	O
hypertrophy-32	BP
,	O
but	O
a	O
high	O
incidence	O
of	O
sudden	BP
cardiac	IP
death-41	IP
.	O

PS388	O
The	O
only	O
infant	O
with	O
the	O
deletion	BG
of	IG
3	IG
alpha	IG
-	IG
globin-11	IG
structural	O
genes	O
had	O
25	O
%	O
hemoglobin	O
Bart	O
'	O
s	O
associated	O
with	O
a	O
moderate	O
microcytic	O
anemia-26	BP
at	O
birth	O
and	O
developed	O
the	O
clinical	O
picture	O
of	O
hemoglobin	BP
H	IP
disease-37	IP
.	O

PS398	O
MECP2-1	BG
has	O
also	O
been	O
implicated	O
in	O
variable	O
mental	BP
retardation-9	IP
phenotypes	O
,	O
including	O
X	O
-	O
linked	O
Mental	BP
Retardation-17	IP
,	O
Fragile	BG
-	IG
X-21	IG
-	O
like	O
Syndrome	O
and	O
Angelman	O
-	O
like	O
(	O
AS	O
)	O
phenotypes	O
.	O

PS405	O
We	O
found	O
significant	O
correlations	O
between	O
germline	BG
CDKN2A	IG
mutations	IG
and	O
melanoma-10	BP
and	O
between	O
dysplastic	O
naevus-14	BP
syndrome	O
phenotype	O
and	O
melanoma-18	BP
,	O
respectively	O
.	O

PS414	O
Mutations	O
in	O
inhibitory	O
GABAA	O
receptor	O
subunit	O
genes	O
(	O
GABRA1-9	BG
,	O
GABRB3-11	BG
,	O
GABRG2-13	BG
and	O
GABRD-15	BG
)	O
have	O
been	O
associated	O
with	O
idiopathic	O
epilepsy	O
syndromes	O
including	O
childhood	O
absence	O
epilepsy	O
,	O
juvenile	O
myoclonic	O
epilepsy	O
,	O
pure	O
febrile	O
seizures-35	BP
,	O
generalized	BP
epilepsy-38	IP
with	O
febrile	O
seizures-41	BP
plus	O
(	O
GEfebrile	O
seizures-45	BP
+	O
)	O
,	O
and	O
Dravet	O
syndrome	O
(	O
also	O
known	O
as	O
severe	O
myoclonic	O
epilepsy	O
in	O
infancy	O
,	O
SMEI	O
)	O
.	O

PS472	O
Apparent	O
mineralocorticoid	O
excess	O
is	O
a	O
syndrome	O
of	O
severe	O
low	BG
-	IG
renin-11	IG
mineralocorticoid	O
hypertension-13	BP
associated	O
with	O
marked	O
hypokalaemia-17	BP
which	O
arises	O
from	O
a	O
congenital	BP
deficiency-23	IP
of	O
11	BG
beta	IG
-	IG
Hydroxysteroid	IG
dehydrogenase-29	IG
.	O

PS571	O
Mutations	BG
of	IG
the	IG
ATP7A	IG
gene-5	IG
(	O
OMIM	O
300011	O
)	O
lead	O
to	O
the	O
Menkes	O
disease	O
involving	O
impaired	O
brain	O
development	O
,	O
neurological	O
degeneration	O
,	O
connective	O
tissue	O
abnormalities	O
,	O
and	O
high	O
lethality	BP
in	IP
early	IP
infancy-32	IP
.	O

PS577	O
Alport	O
syndrome	O
is	O
a	O
type	BG
IV	IG
collagen-7	IG
hereditary	O
disease	O
characterized	O
by	O
progressive	O
hematuric	O
nephritis-14	BP
,	O
hearing	BP
loss-17	IP
,	O
and	O
ocular	O
changes	O
.	O

PS604	O
Germline	O
mutations	O
of	O
a	O
second	O
cancer	O
susceptibility	O
gene	O
BRCA1-9	BG
(	O
ref	O
.	O
5	O
)	O
,	O
are	O
associated	O
with	O
a	O
strong	O
predisposition	O
to	O
ovarian	BP
cancer-24	IP
as	O
well	O
as	O
female	O
breast	BP
cancer-30	IP
.	O

PS699	O
Alterations	O
in	O
tumour	O
suppressor	O
genes	O
(	O
p53-7	BG
,	O
Rb-9	BG
)	O
are	O
associated	O
instead	O
with	O
the	O
most	O
aggressive	O
and	O
poorly	O
differentiated	O
forms	O
of	O
thyroid	BP
cancer-24	IP
,	O
indicating	O
that	O
,	O
in	O
the	O
thyroid	O
tumourigenic	O
process	O
,	O
they	O
represent	O
late	O
genetic	O
events	O
.	O

PS704	O
Complete	O
achromatopsia-2	BP
is	O
a	O
rare	O
autosomal	O
recessive	O
disease	O
associated	O
with	O
CNGA3-11	BG
,	O
CNGB3-13	BG
,	O
GNAT2-15	BG
and	O
PDE6C-17	BG
mutations	O
.	O

PS715	O
The	O
allelic	O
variants	O
in	O
the	O
NOD2	BG
/	IG
CARD15-8	IG
gene	O
G908R-10	BG
,	O
R702W-12	BG
,	O
and	O
1007fs	BG
are	O
strongly	O
and	O
independently	O
associated	O
with	O
susceptibility	O
to	O
Crohn	BP
'	IP
s	IP
disease-27	IP
.	O

PS723	O
Mutations	O
in	O
the	O
CRB1	BG
gene-5	IG
are	O
associated	O
with	O
variable	O
phenotypes	O
of	O
severe	O
retinal	BP
dystrophies-14	IP
,	O
ranging	O
from	O
leber	O
congenital	O
amaurosis	O
to	O
rod	O
-	O
cone	O
dystrophy	O
,	O
also	O
called	O
retinitis	BP
pigmentosa-30	IP
.	O

PS724	O
Moreover	O
,	O
retinal	BP
dystrophies-4	IP
resulting	O
from	O
CRB1-7	BG
mutations	O
may	O
be	O
accompanied	O
by	O
specific	O
fundus	O
features	O
:	O
preservation	O
of	O
the	O
para	O
-	O
arteriolar	O
retinal	O
pigment	O
epithelium	O
(	O
PPretinitis	BP
pigmentosaE-28	IP
)	O
and	O
retinal	BP
telangiectasia-32	IP
with	O
exudation	O
(	O
also	O
referred	O
to	O
as	O
Coats	O
-	O
like	O
vasculopathy-43	BP
)	O
.	O

PS739	O
Mutations	O
in	O
Notch3	BG
gene-4	IG
are	O
responsible	O
for	O
the	O
cerebral	O
autosomal	O
dominant	O
arteriopathy-12	BP
with	O
subcortical	BP
infarcts-15	IP
and	O
leukoencephalopathy-17	BP
.	O

PS762	O
Type	O
I	BG
fibrinogen-3	IG
deficiencies	O
(	O
hypofibrinogenemia	BP
and	IP
afibrinogenemia-8	IP
)	O
are	O
rare	O
congenital	O
disorders	O
characterized	O
by	O
low	O
or	O
unmeasurable	O
plasma	BG
fibrinogen	IG
antigen-21	IG
levels	O
.	O

PS771	O
Both	O
Glycogen	O
storage	O
disease	O
type	O
Ia	O
and	O
Glycogen	O
storage	O
disease	O
type	O
Ib	O
patients	O
manifest	O
phenotypic	O
glucose	BG
-	IG
6	IG
-	IG
phosphatase	IG
deficiency	IG
,	O
characterized	O
by	O
growth	O
retardation	O
,	O
hypoglycemia-28	BP
,	O
hepatomegaly-30	BP
,	O
nephromegaly-32	BP
,	O
hyperlipidemia-34	BP
,	O
hyperuricemia-36	BP
,	O
and	O
lactic	O
academia	O
and	O
the	O
current	O
treatment	O
is	O
a	O
dietary	O
therapy	O
.	O

PS804	O
R7V-1	BG
is	O
a	O
seven	O
-	O
aminoacid	O
peptide	O
epitope	O
derived	O
from	O
cellular	BG
beta	IG
-	IG
2	IG
microglobulin-15	IG
,	O
present	O
on	O
human	O
immunodeficiency-20	BP
virus	O
virion	O
surface	O
in	O
patients	O
with	O
human	O
immunodeficiency-28	BP
virus	O
infection	O
.	O

PS823	O
Mutations	O
in	O
two	O
genes	O
,	O
Endoglin-6	BG
and	O
activin	BG
receptor	IG
-	IG
like	IG
kinase	IG
1-13	IG
(	O
ACVRL1-15	BG
or	O
ALK1-17	BG
)	O
have	O
been	O
associated	O
with	O
hemorrhagic	BP
telangiectasia-24	IP
.	O

PS872	O
Similarly	O
,	O
in	O
patients	O
with	O
Polycythaemia	BP
vera	IP
,	O
homozygous	O
as	O
compared	O
with	O
heterozygous	O
JAK2-14	BG
(	IG
V617F-16	IG
)	IG
correlated	O
with	O
higher	O
levels	O
of	O
polycythaemia-23	BP
rubra	IP
vera	IP
-	IP
1	IP
expression	IP
(	O
P	O
=	O
0	O
.	O
11	O
)	O
.	O

PS893	O
Several	O
biochemical	O
abnormalities	O
have	O
been	O
postulated	O
to	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
the	O
neurological	O
changes	O
in	O
ARG1	BG
deficiency	IG
including	O
hyperargininemia-22	BP
,	O
elevated	O
guanidino	O
compounds	O
and	O
elevated	O
glutamine	O
levels	O
,	O
as	O
well	O
as	O
the	O
hyperammonemia-36	BP
.	O

PS910	O
Carnitine	BG
palmitoyltransferase	IG
II	IG
deficiency	IG
is	O
the	O
most	O
common	O
lipid	O
myopathy-10	BP
in	O
adults	O
and	O
is	O
characterized	O
by	O
exercise	O
-	O
induced	O
pain	O
,	O
stiffness	O
,	O
and	O
myoglobinuria-25	BP
.	O

PS917	O
The	O
correlation	O
of	O
atrophic	O
gastritis	O
and	O
gastric	BP
cancer	IP
with	IP
a	IP
pepsinogen	IP
phenotype	IP
lacking	IP
pepsinogen	IP
A3	IP
can	O
be	O
explained	O
by	O
loss	BG
of	IG
expression	IG
of	IG
pepsinogen	IG
A3	IG
encoding	IG
genes-27	IG
throughout	O
the	O
complete	O
gastric	O
mucosa	O
.	O

PS919	O
The	O
deregulation	O
of	O
ferritin-4	BG
production	O
responsible	O
of	O
Hereditary	O
hyperferritinemia	BP
-	IP
cataract	IP
syndrome-12	IP
is	O
caused	O
by	O
heterogeneous	O
mutations	O
in	O
the	O
iron	O
regulatory	O
element	O
of	O
L	BG
-	IG
ferritin-26	IG
that	O
interfere	O
with	O
the	O
binding	O
of	O
iron	O
regulatory	O
proteins	O
,	O
disrupting	O
the	O
negative	O
control	O
of	O
L	BG
-	IG
ferritin-44	IG
synthesis	O
and	O
causing	O
the	O
constitutive	O
up	O
-	O
regulation	O
of	O
ferritin	BG
L	IG
-	IG
chains-57	IG
.	O

PS925	O
tumor	BG
necrosis	IG
factor	IG
microsatellite	IG
alleles-5	IG
were	O
not	O
related	O
to	O
the	O
prevalences	O
of	O
bone	O
erosion	O
,	O
rheumatoid	O
nodule	O
,	O
sicca	O
syndrome	O
,	O
pulmonary	BP
fibrosis-23	IP
,	O
and	O
seropositivity	O
of	O
rheumatoid	BG
factor-29	IG
in	O
patients	O
with	O
rheumatoid	BP
arthritis-34	IP
.	O

PS927	O
The	O
association	O
of	O
tumor	BG
necrosis	IG
factorb6-6	IG
with	O
the	O
susceptibility	O
to	O
rheumatoid	BP
arthritis-12	IP
depends	O
on	O
the	O
presence	O
of	O
HLA	BG
-	IG
DR4-20	IG
,	O
and	O
the	O
correlation	O
of	O
tumor	BG
necrosis	IG
factora9-28	IG
to	O
rheumatoid	BP
arthritis-31	IP
depends	O
on	O
the	O
absence	O
of	O
HLA	BG
-	IG
DR4-39	IG
.	O

PS929	O
Moreover	O
,	O
tumor	BG
necrosis	IG
factorb6-5	IG
and	O
HLA	BG
-	IG
DR4-9	IG
have	O
a	O
synergistic	O
effect	O
on	O
the	O
susceptibility	O
to	O
rheumatoid	BP
arthritis-19	IP
.	O

PS444	O
Tumor	BG
necrosis	IG
factora3	IG
-	IG
e1-25	IG
and	O
tumor	BG
necrosis	IG
factor	IG
-	IG
308A-31	IG
have	O
a	O
synergistic	O
effect	O
on	O
preventing	O
from	O
rheumatoid	BP
arthritis-40	IP
.	O

PS939	O
Heterozygous	O
GNAS	BG
inactivating	IG
mutations-4	IG
are	O
known	O
to	O
induce	O
pseudohypoparathyroidism	BP
type	IP
1a	IP
when	O
maternally	O
inherited	O
and	O
pseudopseudohypoparathyroidism-16	BP
when	O
paternally	O
inherited	O
.	O

PS983	O
Mutations	O
in	O
the	O
crumbs	BG
homologue	IG
1	IG
gene-7	IG
cause	O
a	O
specific	O
form	O
of	O
retinitis	O
pigmentosa-14	O
that	O
is	O
designated	O
"	O
retinitis	BP
pigmentosa12	IP
"	O
and	O
is	O
characterized	O
by	O
a	O
preserved	O
para	O
-	O
arteriolar	O
retinal	O
pigment	O
epithelium	O
(	O
PPretinitis	BP
pigmentosaE	IP
)	O
and	O
by	O
severe	O
loss	O
of	O
vision	O
at	O
age	O
<	O
20	O
years	O
.	O

PS1002	O
The	O
functional	O
HSPB1	BG
promoter	IG
-	IG
1271G	IG
>	IG
C	IG
variant-9	IG
may	O
affect	O
lung	O
cancer-13	BP
susceptibility	O
and	O
survival	O
by	O
modulating	O
endogenous	O
Heat	BG
-	IG
shock	IG
protein	IG
27-24	IG
synthesis	O
levels	O
.	O

PS1018	O
In	O
regard	O
to	O
ApoE-4	BG
,	O
epsilon4	BG
/	IG
epsilon4	IG
genotype	IG
was	O
absent	O
in	O
the	O
Chilean	O
population	O
analyzed	O
,	O
and	O
only	O
the	O
epsilon2	BG
/	IG
epsilon4	IG
genotype-24	IG
was	O
significantly	O
increased	O
in	O
both	O
mild	O
cognitive	BP
impairment-32	IP
and	O
Alzheimer	O
'	O
s	O
disease	O
patients	O
patients	O
.	O

PS1061	O
Interaction	O
of	O
MEF2C-3	BG
with	O
the	O
deleted	O
febrile	O
seizure-8	BP
(	O
FEB4	O
)	O
and	O
juveline	O
myoclonic	O
epilepsy	O
(	O
EJM4	O
)	O
loci	O
plus	O
the	O
G	BG
-	IG
protein	IG
receptor-25	IG
(	O
GPR98-27	BG
/	O
MASS1-29	BG
/	O
Usher	O
syndrome	O
)	O
gene	O
may	O
moderate	O
the	O
phenotype	O
,	O
perhaps	O
through	O
common	O
regulation	O
by	O
calcium	O
.	O

PS1069	O
This	O
study	O
examines	O
the	O
relationship	O
of	O
genotype	O
to	O
phenotype	O
in	O
14	O
unselected	O
patients	O
who	O
were	O
found	O
to	O
harbour	O
the	O
A3243G	O
transition	O
in	O
the	O
mitochondrial	BG
transfer	IG
RNALeu-26	IG
(	O
UUR-28	BG
)	O
gene	O
commonly	O
associated	O
with	O
the	O
syndrome	O
of	O
mitochondrial	BP
encephalopathy-38	IP
,	O
lactic	BP
acidosis-41	IP
and	O
strokes-43	BP
(	O
MELAS	O
)	O
.	O

PS1088	O
lipoprotein	BG
lipase	IG
S447X	IG
mutation-27	IG
is	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
pancreatic	BP
calcification-36	IP
and	O
steatorrhea	O
than	O
those	O
previously	O
known	O
factors	O
in	O
hyperlipidemic	BP
pancreatitis-46	IP
patients	O
.	O

PS1103	O
In	O
summary	O
,	O
we	O
show	O
that	O
the	O
COX	BG
-	IG
2	IG
-	IG
765	IG
G	IG
allele	IG
promoter	IG
polymorphism-16	IG
is	O
significantly	O
associated	O
with	O
gastric	BP
cancer-22	IP
when	O
compared	O
with	O
the	O
normal	O
control	O
group	O
,	O
but	O
does	O
not	O
appear	O
to	O
be	O
related	O
directly	O
to	O
COX	O
-	O
2	O
expression	O
pattern	O
in	O
gastric	BP
cancer-47	IP
.	O

PS1140	O
The	O
methods	O
are	O
applied	O
to	O
a	O
study	O
of	O
the	O
penetrance	O
for	O
breast	BP
cancer-13	IP
of	O
BRCA1-15	BG
and	O
BRCA2-17	BG
mutations	O
among	O
Ashkenazi	O
Jews	O
.	O

PS1319	O
We	O
describe	O
a	O
male	O
infant	O
with	O
carnitine	BG
palmitoyltransferase	IG
2-9	IG
deficiency	O
who	O
presented	O
with	O
acute	O
encephalopathy-15	BP
related	O
to	O
human	O
herpesvirus	O
-	O
6	O
infection	O
.	O

PS1330	O
PON1	O
status	O
,	O
which	O
includes	O
PON1	O
level	O
as	O
well	O
as	O
PON1192	BG
genotype-12	IG
,	O
may	O
be	O
a	O
better	O
predictor	O
for	O
cardiovascular	BP
disease-21	IP
or	O
organophosphate	O
susceptibility	O
than	O
PON1	BG
genotype-27	IG
alone	O
.	O

PS1348	O
Multiple	O
Endocrine	BG
Neoplasia2-3	IG
refers	O
to	O
the	O
inherited	O
forms	O
of	O
medullary	O
thyroid	BP
carcinoma-12	IP
which	O
is	O
associated	O
with	O
phaechromocytoma	O
and	O
parathyroid	O
tumours	O
in	O
Multiple	O
Endocrine	O
Neoplasia2A	O
,	O
phaechromocytoma-26	BP
and	O
mucosal	O
neuromas	O
in	O
Multiple	O
Endocrine	O
Neoplasia2B-33	BP
.	O

PS1373	O
Patients	O
with	O
isolated	O
hypodontia-4	BP
caused	O
by	O
PAX9-7	BG
or	O
MSX1-9	BG
mutation	O
reported	O
before	O
May	O
2007	O
were	O
enrolled	O
.	O

PS1398	O
Analyses	O
that	O
took	O
into	O
account	O
confounding	O
factors	O
confirmed	O
the	O
negative	O
association	O
of	O
hemoglobin	BG
C-14	IG
with	O
malaria-16	BP
attack	O
(	O
P	O
=	O
0	O
.	O
0074	O
)	O
and	O
evidenced	O
a	O
negative	O
correlation	O
between	O
hemoglobin	BG
C-32	IG
and	O
parasitemia-34	BP
(	O
P	O
=	O
0	O
.	O
0009	O
)	O
.	O

PS1445	O
The	O
risk	O
of	O
therapeutic	BP
failure-5	IP
after	O
chloroquine	O
was	O
increased	O
by	O
the	O
presence	O
of	O
pfcrt	O
K76T	O
(	O
Day	O
28	O
,	O
odds	O
ratio	O
=	O
7	O
.	O
2	O
[	O
95	O
%	O
CI	O
:	O
4	O
.	O
5	O
-	O
11	O
.	O
5	O
]	O
)	O
,	O
pfmdr1	BG
N86Y-42	IG
was	O
associated	O
with	O
both	O
chloroquine	O
(	O
Day	O
28	O
,	O
odds	O
ratio	O
=	O
1	O
.	O
8	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
3	O
-	O
2	O
.	O
4	O
]	O
)	O
and	O
amodiaquine	BP
failures-74	IP
(	O
odds	O
ratio	O
=	O
5	O
.	O
4	O
[	O
95	O
%	O
CI	O
:	O
2	O
.	O
6	O
-	O
11	O
.	O
3	O
,	O
p	O
<	O
0	O
.	O
001	O
]	O
)	O
.	O

PS1486	O
To	O
test	O
the	O
hypothesis	O
that	O
polymorphisms	BG
of	IG
ESR1-8	IG
,	O
the	O
gene	O
encoding	O
estrogen	BG
receptor	IG
alpha-15	IG
,	O
are	O
associated	O
with	O
susceptibility	O
,	O
clinical	O
phenotype	O
,	O
and	O
progression	O
of	O
breast	BP
cancer-29	IP
.	O

PS1487	O
Frequencies	O
of	O
single	O
-	O
nucleotide	O
polymorphismss	O
were	O
compared	O
between	O
cases	O
and	O
controls	O
to	O
identify	O
single	O
-	O
nucleotide	O
polymorphismss	O
associated	O
with	O
cancer-21	BP
susceptibility	O
and	O
between	O
cases	O
with	O
different	O
clinical	O
phenotypes	O
to	O
determine	O
the	O
role	O
of	O
ESR1	BG
polymorphism	IG
in	O
cancer-38	BP
progression	O
.	O

PS1492	O
Multiple	O
endocrine	O
neoplasia-3	BP
type	O
2	O
is	O
caused	O
by	O
autosomal	O
dominant	O
gain	O
-	O
of	O
-	O
function	O
mutations	O
in	O
the	O
RET	BG
proto	IG
-	IG
oncogene-22	IG
,	O
which	O
includes	O
multiple	O
endocrine	O
neoplasia-34	BP
type	O
2A	O
,	O
type	O
2B	O
(	O
MEN	O
2B	O
)	O
,	O
and	O
familial	O
medullary	O
thyroid	BP
carcinoma-50	IP
.	O

PS1541	O
A	O
review	O
of	O
all	O
published	O
mutations	O
suggests	O
that	O
mutation	O
in	O
the	O
C	O
-	O
terminal	O
coiled	O
coil	O
region	O
or	O
truncation	O
of	O
the	O
tailpiece	O
is	O
associated	O
with	O
haematological	O
-	O
only	O
phenotype	O
,	O
while	O
mutation	O
of	O
the	O
head	BG
ATPase	IG
domain-37	IG
frequently	O
is	O
associated	O
with	O
nephropathy-42	BP
and	O
/	O
or	O
hearing	BP
loss-47	IP
.	O

PS1597	O
Haploinsufficiency	O
of	O
a	O
more	O
proximal	O
region	O
,	O
located	O
on	O
10p13	BG
-	IG
10p14-12	IG
,	O
designated	O
as	O
DGCR2-16	BG
is	O
associated	O
with	O
congenital	BP
heart	IP
defects-22	IP
and	O
thymus	O
hypoplasia-25	BP
/	O
aplasia	O
or	O
T	O
cell	O
defect	O
.	O

PS1629	O
Although	O
both	O
Juvenile	BP
polyposis-4	IP
and	O
Juvenile	BP
polyposis	IP
-	IP
hemorrhagic	IP
telangiectasia-10	IP
are	O
caused	O
by	O
SMAD4	BG
mutations-15	IG
,	O
a	O
possible	O
genotype	O
:	O
phenotype	O
correlation	O
was	O
noted	O
as	O
all	O
of	O
the	O
SMAD4	BG
mutations-30	IG
in	O
the	O
Juvenile	BP
polyposis	IP
-	IP
hemorrhagic	IP
telangiectasia	IP
patients	O
were	O
clustered	O
in	O
the	O
COOH	O
-	O
terminal	O
MH2	O
domain	O
of	O
the	O
protein	O
.	O

PS1650	O
There	O
was	O
significant	O
phenotypic	O
variability	O
,	O
but	O
the	O
presence	O
of	O
skeletal	O
muscle	O
involvement	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
supraventricular	BP
arrhythmia-23	IP
(	O
p	O
=	O
0	O
.	O
003	O
)	O
,	O
conduction	O
defects	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
,	O
and	O
"	O
mildly	O
"	O
dilated	BP
cardiomyopathy-47	IP
(	O
p	O
=	O
0	O
.	O
006	O
)	O
were	O
predictors	O
of	O
lamin	BG
A	IG
/	IG
C	IG
gene	IG
mutations-63	IG
.	O

PS1669	O
The	O
polymorphisms	O
rs9858542	BG
(	O
BSN	O
)	O
and	O
rs3197999-8	BG
(	O
MST1-10	O
)	O
,	O
on	O
3p21	O
locus	O
,	O
have	O
been	O
found	O
associated	O
with	O
susceptibility	O
to	O
inflammatory	BP
bowel	IP
disease-26	IP
.	O

PS1686	O
In	O
conclusion	O
,	O
SMN2	BG
alleles-5	IG
are	O
not	O
functionally	O
equivalent	O
among	O
Spinal	BP
muscular	IP
atrophy-13	IP
patients	O
,	O
although	O
in	O
general	O
the	O
SMN2-20	BG
copy	O
number	O
is	O
correlated	O
with	O
the	O
severity	O
of	O
Spinal	BP
muscular	IP
atrophy-31	IP
.	O

PS1686	O
Human	BG
leukocyte	IG
antigen	IG
-	IG
DQB1	IG
alleles-60	IG
are	O
associated	O
with	O
susceptibility	BP
or	IP
resistance	IP
to	IP
Gastric	IP
cancer-69	IP
and	O
also	O
influence	O
its	O
clinical	O
features	O
.	O

PS1718	O
In	O
conclusion	O
,	O
human	BG
leukocyte	IG
antigen	IG
-	IG
DQB1	IG
(	IG
*	IG
)	IG
0602	IG
confers	O
susceptibility	O
to	O
gastric	BP
cancer-17	IP
,	O
especially	O
for	O
male	O
Taiwanese	O
and	O
proximal	O
tumor	O
location	O
,	O
while	O
human	BG
leukocyte	IG
antigen	IG
-	IG
DQB1	IG
(	IG
*	IG
)	IG
0301	IG
may	O
have	O
a	O
protective	O
effect	O
on	O
Gastric	BP
cancer-45	IP
,	O
probably	O
through	O
resistance	O
to	O
Helicobacter	O
pylori	O
infection	O
.	O

PS1755	O
Mutations	O
of	O
the	O
Cu	BG
/	IG
Zn	IG
superoxide	IG
dismutase	IG
gene-9	IG
(	O
SOD1-11	BG
)	O
are	O
responsible	O
for	O
20	O
%	O
of	O
autosomal	O
dominant	O
familial	O
Amyotrophic	BP
lateral	IP
sclerosis-24	IP
.	O

PS1796	O
In	O
the	O
pediatric	O
cohort	O
the	O
associations	O
of	O
TNFSF15-8	BG
,	O
NKX2	BG
-	IG
3-12	IG
with	O
Crohn	O
'	O
s	O
disease	O
,	O
and	O
PTGER4-20	BG
,	O
NKX2	BG
-	IG
3-24	IG
,	O
ZNF365-26	BG
,	O
IFNG-28	BG
,	O
PSMG1-30	BG
with	O
ulcerative	BP
colitis-33	IP
,	O
were	O
confirmed	O
.	O

PS1803	O
We	O
report	O
a	O
novel	O
mutation	O
of	O
the	O
factor	BG
VII	IG
gene-10	IG
that	O
creates	O
the	O
amino	O
acid	O
change	O
Ser	O
103	O
to	O
Gly	O
,	O
which	O
resulted	O
in	O
severe	O
factor	BG
VII-27	IG
deficiency	O
with	O
reduced	BP
factor	IP
VII	IP
antigen-33	IP
.	O

PS1866	O
In	O
neuroblastoma-2	BP
,	O
N	BG
-	IG
myc	IG
amplification	IG
and	O
loss	O
of	O
heterozygosity	O
for	O
the	O
short	O
arm	O
of	O
chromosome	BP
1	IP
(	IP
LOH	IP
1p	IP
)	IP
are	O
common	O
genetic	O
abnormalities	O
.	O

PS1916	O
We	O
replicated	O
the	O
genetic	O
association	O
with	O
rs13277113	O
(	O
p	O
=	O
0	O
.	O
0009	O
,	O
OR	O
1	O
.	O
46	O
)	O
and	O
rs2736340	O
(	O
p	O
=	O
0	O
.	O
0001	O
,	O
OR	O
1	O
.	O
63	O
)	O
from	O
C8orf13	BG
-	IG
BLK-37	IG
(	O
8p23	BG
.	IG
1-41	IG
,	O
associated	O
with	O
rheumatoid	BP
arthritis-46	IP
and	O
systemic	BP
lupus	IP
erythematosus-50	IP
)	O
,	O
and	O
rs763361	O
(	O
p	O
=	O
0	O
.	O
03	O
)	O
from	O
CD226-63	BG
(	O
18q22	BG
.	IG
3-67	IG
,	O
associated	O
with	O
multiple	BP
sclerosis-72	IP
and	O
type	O
1	O
diabetes	O
)	O
in	O
the	O
Colombian	O
population	O
.	O

PS1917	O
Our	O
results	O
demonstrate	O
that	O
the	O
IL2	BG
/	IG
IL21-8	IG
region	IG
,	O
C8orf13	BG
-	IG
BLK-13	IG
,	O
and	O
CD226-16	BG
influence	O
rheumatoid	BP
arthritis-19	IP
in	O
Colombians	O
,	O
and	O
rheumatoid	BP
arthritis-25	IP
shares	O
some	O
of	O
the	O
pathogenic	O
mechanisms	O
associated	O
with	O
other	O
autoimmune	BP
diseases-36	IP
.	O

PS1947	O
We	O
have	O
previously	O
shown	O
that	O
the	O
c1	BG
/	IG
c1-9	IG
genotype	O
recognized	O
by	O
Rsa	BG
I-14	IG
in	O
the	O
5	O
'	O
-	O
regulatory	O
region	O
of	O
the	O
cytochrome	BG
P4502E1-25	IG
may	O
be	O
a	O
susceptibility	O
factor	O
for	O
developing	O
esophageal	BP
cancer-34	IP
and	O
lung	BP
cancer-37	IP
in	O
Chinese	O
.	O

PS1962	O
Mutations	BG
in	IG
the	IG
Aristaless	IG
-	IG
related	IG
homeobox	IG
gene-8	IG
are	O
associated	O
with	O
a	O
wide	O
variety	O
of	O
neurologic	O
disorders	O
including	O
lissencephaly	O
,	O
hydrocephaly-21	BP
,	O
West	O
syndrome	O
,	O
Partington	O
syndrome	O
,	O
and	O
X	BP
-	IP
linked	IP
intellectual	IP
disability-34	IP
with	O
or	O
without	O
epilepsy	O
.	O

PS2029	O
Abnormal	BG
FOXP3	IG
expression	IG
results	O
in	O
defective	O
regulatory	O
functions	O
of	O
T	O
cells	O
,	O
which	O
in	O
turn	O
cause	O
a	O
systemic	BP
T	IP
-	IP
cell	IP
-	IP
mediated	IP
autoaggressive	IP
disorder-25	IP
,	O
now	O
called	O
immune	O
dysregulation	O
,	O
polyendocrinopathy	BP
autoimmune	IP
enteropathy	IP
X	IP
-	IP
linked	IP
syndrome	IP
.	O

PS2037	O
Familial	BP
hypercholesterolemia-2	IP
,	O
characterized	O
by	O
isolated	O
elevation	O
of	O
plasmatic	O
low	O
-	O
density	O
lipoprotein	O
cholesterol	O
and	O
premature	O
coronary	O
heart	O
disease	O
,	O
is	O
associated	O
with	O
mutations	O
in	O
three	O
major	O
genes	O
:	O
low	BG
-	IG
density	IG
lipoprotein	IG
receptor-34	IG
,	O
apolipoprotein	BG
B	IG
and	IG
proprotein	IG
convertase	IG
subtilisin	IG
/	IG
kexin	IG
9-44	IG
.	O

PS2043	O
Large	O
deletions	O
including	O
the	O
TWIST	BG
gene-6	IG
have	O
been	O
identified	O
in	O
some	O
patients	O
with	O
learning	BP
disabilities-15	IP
or	O
mental	BP
retardation-18	IP
,	O
which	O
are	O
not	O
typically	O
part	O
of	O
the	O
Saethre	O
-	O
Chotzen	O
syndrome	O
.	O

PS2050	O
Since	O
glycosylated	O
hemoglobin-3	BG
is	O
found	O
inside	O
red	O
blood	O
cells	O
,	O
the	O
relationship	O
between	O
RH	O
genetic	O
variability	O
and	O
Hb	BG
A-19	IG
(	IG
1c-21	IG
)	IG
level	O
suggests	O
that	O
RH	BG
proteins-27	IG
may	O
influence	O
glucose	O
transport	O
through	O
red	O
cell	O
membrane	O
and	O
/	O
or	O
hemoglobin	O
glycation-40	BP
.	O

PS2071	O
In	O
multiple	BP
sclerosis-3	IP
patients	O
confirmed	O
as	O
Arylsulfatase	BG
A	IG
-	IG
PD	IG
mutations	IG
carriers	O
,	O
arylsulfatase-14	BG
activity	O
was	O
determined	O
in	O
leukocyte	O
homogenates	O
by	O
spectrophotometry	O
.	O

PS2085	O
A	O
good	O
correlation	O
was	O
observed	O
between	O
enhanced	O
lung	BP
cancer-9	IP
risk	O
and	O
restriction	O
fragment	O
length	O
polymorphisms	O
of	O
the	O
P450IA1	BG
gene-19	IG
with	O
the	O
restriction	O
enzyme	O
MspI-24	BG
.	O

PS2090	O
The	O
germline	O
mutations	O
in	O
GATA4-5	BG
,	O
NKX2	BG
.	IG
5-9	IG
,	O
and	O
TFAP2B	BG
genes-13	IG
have	O
been	O
identified	O
to	O
be	O
responsible	O
for	O
congenital	BP
heart	IP
disease-23	IP
.	O

PS2093	O
RESULTS	O
:	O
Fifteen	O
heterozygous	O
mutations	BG
in	IG
the	IG
GATA4	IG
gene-9	IG
were	O
identified	O
in	O
30	O
congenital	BP
heart	IP
disease-16	IP
patients	O
,	O
including	O
a	O
novel	O
heterozygous	O
missense	BG
mutation	IG
(	IG
c	IG
.	IG
788	IG
C	IG
>	IG
G	IG
)	IG
of	IG
GATA4-34	BG
in	O
one	O
patient	O
with	O
ventricular	BP
septal	IP
defect-41	IP
.	O

PS2097	O
A	BG
sequence	IG
variant	IG
(	IG
rs7216389	IG
-	IG
T	IG
)	IG
near	IG
the	IG
ORMDL3	IG
gene-12	IG
on	O
chromosome	O
17q21	O
was	O
recently	O
found	O
to	O
be	O
associated	O
with	O
childhood	O
asthma-24	BP
.	O

PS2099	O
Thus	O
,	O
the	O
contribution	O
of	O
rs7216389	BG
-	IG
T-8	IG
to	O
the	O
development	O
of	O
asthma-13	BP
is	O
unlikely	O
to	O
operate	O
only	O
through	O
an	O
impact	O
on	O
the	O
expression	O
of	O
ORMDL3-26	BG
or	O
GSDMB	BG
genes-29	IG
.	O

PS2175	O
Mutations	O
in	O
SLC3A1-3	BG
,	O
which	O
encodes	O
rBAT	O
,	O
cause	O
Type	BP
I	IP
cystinuria-12	IP
,	O
and	O
mutations	O
in	O
SLC7A9-17	BG
,	O
which	O
encodes	O
a	O
putative	O
subunit	O
of	O
rBAT-25	BG
(	O
b	O
(	O
o	O
,	O
+	O
)	O
AT	O
)	O
,	O
cause	O
non	BP
-	IP
Type	IP
I	IP
cystinuria-41	IP
.	O

PS2188	O
Matrix	BG
metalloproteinase	IG
-	IG
3-4	IG
is	O
implicated	O
in	O
the	O
formation	O
of	O
atherosclerotic	O
plaques	O
,	O
and	O
the	O
Matrix	BG
metalloproteinase	IG
-	IG
3	IG
-	IG
1612	IG
5A	IG
/	IG
6A-24	IG
polymorphism	O
is	O
associated	O
with	O
myocardial	BP
infarction-30	IP
and	O
stable	O
coronary	BP
artery	IP
disease-35	IP
.	O

PS2323	O
Even	O
though	O
the	O
VEGFD	BG
gene-5	IG
was	O
interrupted	O
by	O
the	O
X	O
;	O
9	O
translocation	O
,	O
it	O
seems	O
unlikely	O
that	O
VEGFD-19	BG
is	O
causing	O
the	O
translocation	O
patient	O
'	O
s	O
Hypomagnesemia-27	BP
with	O
secondary	O
hypocalcemia	BP
-	IP
like	IP
phenotype-33	IP
.	O

PS2325	O
Polymorphism	BG
of	IG
A1166C	IG
gene	IG
of	IG
type	IG
1	IG
vascular	IG
receptor	IG
of	IG
angiotensin	IG
II	IG
(	IG
AGTR1	IG
)	IG
contributes	O
to	O
formation	O
of	O
arterial	BP
hypertension-21	IP
signs	O
diversity	O
in	O
diabetes	BP
mellitus-26	IP
type	O
2	O
patients	O
.	O

PS2329	O
Primary	BG
dysfunction	IG
of	IG
Phenylalanine	IG
hydroxylase-5	IG
caused	O
by	O
mutations	BG
in	IG
the	IG
Phenylalanine	IG
hydroxylase	IG
gene-13	IG
results	O
in	O
hyperphenylalaninemia-16	BP
,	O
which	O
may	O
impair	O
cognitive	O
development	O
unless	O
corrected	O
by	O
dietary	O
restriction	O
of	O
phenylalanine	O
.	O

PS2340	O
As	O
rare	O
18q	O
interstitial	O
deletions	O
affecting	O
multiple	O
genes	O
including	O
SET	BG
binding	IG
protein	IG
1	IG
gene-14	IG
correlate	O
with	O
a	O
milder	O
phenotype	O
,	O
including	O
minor	O
physical	O
anomalies	O
and	O
developmental	O
and	O
expressive	O
speech	BP
delay-30	IP
,	O
mutations	BG
in	IG
SET	IG
binding	IG
protein	IG
1	IG
gene-38	IG
are	O
thought	O
to	O
result	O
in	O
a	O
gain	O
-	O
of	O
-	O
function	O
or	O
a	O
dominant	O
-	O
negative	O
effect	O
.	O

PS2358	O
We	O
have	O
shown	O
that	O
the	O
combination	BG
of	IG
the	IG
additional	IG
mutations	IG
H208Y	IG
,	IG
R211K	IG
,	IG
and	IG
L214F-16	IG
in	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
reverse	O
transcriptase	O
may	O
influence	O
Zidovudine	BP
resistance-28	IP
and	O
should	O
be	O
considered	O
when	O
assessing	O
Zidovudine	O
resistance	O
.	O

PS2416	O
These	O
results	O
suggest	O
that	O
susceptibility	O
to	O
arylamine	O
-	O
induced	O
bladder	BP
cancer-11	IP
might	O
be	O
influenced	O
by	O
both	O
hepatic	O
and	O
bladder	BG
N	IG
-	IG
acetyltransferase-22	IG
and	O
that	O
the	O
N	BG
-	IG
acetyltransferase-28	IG
genotype	O
might	O
be	O
a	O
useful	O
biomarker	O
for	O
screening	O
high	O
risk	O
individuals	O
for	O
bladder	BP
cancer-42	IP
resulting	O
from	O
exposure	O
to	O
arylamines	O
.	O

PS2431	O
The	O
polymorphisms	BG
LTA	IG
rs1041981-4	IG
and	O
LGALS2	BG
rs7291467-7	IG
were	O
associated	O
with	O
coronary	BP
stenosis-12	IP
index	O
with	O
odds	O
ratios	O
of	O
1	O
.	O
54	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
17	O
-	O
2	O
.	O
01	O
;	O
AA	O
+	O
CA	O
over	O
CC	O
)	O
and	O
1	O
.	O
62	O
(	O
95	O
%	O
CI	O
,	O
1	O
.	O
11	O
-	O
2	O
.	O
37	O
;	O
TT	O
over	O
CC	O
+	O
CT	O
)	O
,	O
respectively	O
.	O

PS2362	O
Proteasome	BG
subunit	IG
a	IG
type	IG
6	IG
rs1048990-71	IG
was	O
not	O
associated	O
with	O
coronary	BP
stenosis	IP
index	O
.	O

PS2469	O
Germline	BG
RET	IG
proto	IG
-	IG
oncogene	IG
mutations	IG
are	O
the	O
genetic	O
causes	O
of	O
multiple	BP
endocrine	IP
neoplasia-14	IP
type	O
2	O
and	O
a	O
strong	O
genotype	O
-	O
phenotype	O
correlation	O
exists	O
,	O
particularly	O
between	O
a	O
specific	O
RET	BG
codon	IG
mutation-32	IG
and	O
the	O
(	O
a	O
)	O
age	O
-	O
related	O
onset	O
and	O
(	O
b	O
)	O
thyroid	O
tumor	O
progression	O
,	O
from	O
C	BP
-	IP
cell	IP
hyperplasia-54	IP
to	O
medullary	O
thyroid	BP
carcinoma-58	IP
and	O
,	O
ultimately	O
,	O
to	O
nodal	O
metastases	O
.	O

PS2502	O
The	O
homozygosity	O
of	O
M694V	BG
mutation	IG
in	IG
the	IG
MEFV	IG
gene-9	IG
is	O
associated	O
with	O
arthritis-13	BP
in	O
Familial	BP
Mediterranean	IP
fever-17	IP
patients	O
.	O

PS2519	O
Achondrogenesis	O
II	O
-	O
hypochondrogenesis	O
and	O
severe	O
spondyloepiphyseal	BP
dysplasia	IP
congenita-9	IP
are	O
lethal	O
forms	O
of	O
dwarfism-14	BP
caused	O
by	O
dominant	O
mutations	IG
in	IG
the	IG
type	IG
II	IG
collagen	IG
gene	IG
(	IG
COL2A1	IG
)	O
.	O

PS2526	O
Auditory	O
and	O
vestibulo	O
-	O
ocular	O
functions	O
were	O
examined	O
in	O
a	O
Dutch	O
family	O
with	O
autosomal	O
dominantly	O
inherited	O
sensorineural	O
hearing	BP
impairment-19	IP
caused	O
by	O
a	BG
208C	IG
>	IG
T	IG
mutation	IG
in	IG
the	IG
COCH	IG
gene	IG
,	IG
located	IG
in	IG
chromosome	IG
14q12	IG
-	IG
q13	IG
(	IG
DFNA9	IG
)	IG
.	O

PS2536	O
Recent	O
studies	O
have	O
implicated	O
that	O
the	BG
rs11614913	IG
SNP	IG
in	IG
miR	IG
-	IG
196a2-12	IG
may	O
be	O
associated	O
with	O
susceptibility	O
to	O
lung	BP
cancer-20	IP
,	O
congenital	BP
heart	IP
disease-24	IP
,	O
breast	BP
cancer-27	IP
,	O
as	O
well	O
as	O
reduced	O
survival	O
in	O
non	BP
-	IP
small	IP
cell	IP
lung	IP
cancer-40	IP
.	O

PS2590	O
Endothelin	BG
-	IG
B	IG
receptor-4	IG
(	O
EDNRB-6	BG
)	O
signaling	O
pathway	O
is	O
associated	O
for	O
Hirschsprung	BP
disease-14	IP
.	O

PS2637	O
We	O
previously	O
reported	O
a	O
familial	O
G504S	O
mutation	O
in	O
the	O
type	BG
II	IG
collagen-12	IG
(	O
COL2A1-14	BG
)	O
gene	O
resulting	O
in	O
Spondyloepiphyseal	BP
dysplasia-20	IP
congenita	O
.	O

PS2648	O
Severe	O
pancreatic	BP
insufficiency-3	IP
was	O
associated	O
with	O
the	O
presence	O
of	O
two	O
Cystic	BG
fibrosisTR	IG
gene	IG
mutations-14	IG
(	O
DeltaF508-16	BG
,	O
N1303K-18	BG
,	O
Cystic	BG
fibrosisTR	IG
dele	IG
2-23	IG
,	O
3	O
(	O
21kb	O
)	O
,	O
G542X	O
,	O
1717	O
-	O
1G	O
-	O
A	O
,	O
R533X	O
,	O
W1282X	O
,	O
621GT	O
,	O
2183AAG	O
,	O
R560T	O
,	O
2184insA	O
and	O
DeltaI507	O
,	O
G551D	O
,	O
895T	O
)	O
and	O
mild	O
insufficiency	O
with	O
the	O
presence	O
of	O
at	O
least	O
one	O
mutation	O
(	O
R117H	O
,	O
3171insC	O
,	O
A155P2	O
,	O
138insL	O
,	O
296	O
+	O
1G	O
-	O
A	O
,	O
E92GK	O
,	O
E217G	O
,	O
2789	O
+	O
5G	O
-	O
A	O
.	O
3849	O
+	O
1kbC	O
-	O
T	O
/	O
3849	O
+	O
1kbC	O
-	O
T	O
)	O
genotype	O
resulted	O
in	O
high	BG
elastase	IG
-	IG
1	IG
-	IG
values-112	IG
.	O

PS2650	O
OTX2	BG
mutations	IG
are	O
associated	O
with	O
severe	O
ocular	O
phenotypes	O
and	O
central	O
nervous	O
system	O
abnormalities	O
such	O
as	O
seizures-16	BP
,	O
short	BP
stature-19	IP
and	O
developmental	O
delay	O
,	O
combined	O
pituitary	BP
hormone	IP
deficiency-27	IP
,	O
structural	O
abnormalities	O
of	O
the	O
pituitary	O
gland	O
and	O
early	O
onset	O
retinal	BP
dystrophy-39	IP
.	O

PS2651	O
P450c17	O
deficiency	O
(	O
17OHD	O
)	O
,	O
caused	O
by	O
mutation	BG
in	IG
CYP17A1	IG
gene-12	IG
,	O
is	O
characterized	O
by	O
severe	O
hypertension	BP
-	IP
hypokalemia-20	IP
,	O
sexual	O
infantilism	O
in	O
females	O
,	O
and	O
pseudohermaphroditism-28	BP
in	O
males	O
.	O

PS2658	O
Congenital	O
erythropoietic	BP
porphyria-3	IP
is	O
a	O
rare	O
inborn	O
error	O
of	O
metabolism	O
that	O
results	O
from	O
a	O
deficient	O
activity	O
of	O
uroporphyrinogen	BG
III	IG
synthase-20	IG
(	O
URO	BG
-	IG
synthase-24	IG
)	O
.	O

PS2687	O
X	O
-	O
linked	O
myotubular	O
myopathy-5	BP
is	O
a	O
severe	O
neuromuscular	O
disease	O
of	O
infancy	O
caused	O
by	O
mutations	BG
of	IG
myotubular	IG
myopathy1-18	IG
,	O
which	O
encodes	O
the	O
phosphoinositide	BG
lipid	IG
phosphatase-25	IG
,	O
myotubularin	O
.	O

PS2704	O
In	O
patients	O
with	O
chronic	O
systolic	O
heart	BP
failure-7	IP
,	O
the	O
chymase	BG
-	IG
1	IG
polymorphism	IG
was	O
related	O
to	O
nonischemic	O
etiology	O
of	O
heart	BP
failure-21	IP
.	O

PS2740	O
Regarding	O
unique	O
symptoms	O
in	O
each	O
case	O
,	O
congenital	BP
fibrosis-9	IP
of	O
the	O
extraocular	O
muscles	O
found	O
only	O
in	O
Case	O
1	O
may	O
be	O
caused	O
by	O
KIF21A	BG
deletion	IG
and	O
hearing	BP
loss-27	IP
and	O
cleft	BP
palate-30	IP
in	O
Case	O
2	O
by	O
COL2A1	BG
defect	IG
.	O

PS2763	O
Association	O
studies	O
have	O
reported	O
that	O
common	O
single	O
-	O
nucleotide	O
polymorphisms	O
in	O
KCNE1-12	BG
and	O
SCN5A-14	BG
may	O
predispose	O
to	O
Atrial	BP
fibrillation-19	IP
.	O

PS2771	O
Heterozygous	O
missense	O
mutations	O
of	O
transient	O
receptor	O
potential	O
vanilloid	BG
4	IG
channel-10	IG
cause	O
a	O
spectrum	O
of	O
skeletal	O
disorders	O
,	O
including	O
brachyolmia-19	BP
,	O
spondylometaphyseal	BP
dysplasia-22	IP
Kozlowski	O
type	O
,	O
metatropic	BP
dysplasia-27	IP
,	O
parastremmatic	O
dysplasia	O
,	O
and	O
spondyloepimetaphyseal	O
dysplasia	O
Maroteaux	O
type	O
.	O

PS2827	O
Mutations	BG
in	IG
the	IG
skeletal	IG
muscle	IG
alpha	IG
-	IG
actin	IG
gene	IG
(	O
ACTA1-11	BG
)	O
cause	O
a	O
range	O
of	O
pathologically	O
defined	O
congenital	BP
myopathies-20	IP
.	O

PS2839	O
There	O
was	O
also	O
a	O
significant	O
correlation	O
between	O
p21-8	BG
(	O
waf-10	BG
)	O
loss	O
and	O
chronic	O
active	O
hepatitis	O
(	O
P	O
=	O
0	O
.	O
01	O
)	O
as	O
well	O
as	O
between	O
mdm2-28	BG
,	O
c	BG
-	IG
erbB2-32	IG
and	O
cirrhosis-34	BP
(	O
P	O
=	O
0	O
.	O
025	O
and	O
0	O
.	O
001	O
)	O
in	O
hepatocellular	BP
carcinoma-48	IP
cases	O
.	O

PS2846	O
Mutations	O
in	O
FGFR1-3	BG
and	O
TWIST1-5	BG
have	O
been	O
reported	O
to	O
affect	O
the	O
timing	O
of	O
calvarial	O
suture	O
fusion	O
resulting	O
in	O
craniosynostosis-19	BP
and	O
facial	BP
abnormalities-22	IP
.	O

PS2931	O
Hereditary	O
cystathioninuria-2	BP
is	O
presumed	O
to	O
be	O
caused	O
by	O
deficiency	BG
of	IG
the	IG
activity	IG
of	IG
cystathionine	IG
gamma	IG
-	IG
lyase-17	IG
(	O
cystathionase-19	BG
;	O
CTH	BG
EC	IG
4	IG
.	IG
4	IG
.	IG
1	IG
.	IG
1-29	IG
)	O
,	O
which	O
is	O
normally	O
required	O
for	O
the	O
conversion	O
of	O
methionine	O
into	O
cysteine	O
.	O

PS2934	O
Polymorphic	BG
expression	IG
of	IG
arylamin	IG
N-acetyltransferase	IG
(	IG
EC	IG
2	IG
.	IG
3	IG
.	IG
1	IG
.	IG
5	IG
)	IG
may	O
be	O
a	O
differential	O
risk	O
factor	O
in	O
metabolic	O
activation	O
of	O
arylamin	BG
carcinogens	IG
and	O
susceptibility	O
to	O
cancers	BP
related	O
to	O
arylamin	O
exposures	O
.	O

PS2959	O
Moreover	O
,	O
high	BG
-	IG
density	IG
lipoprotein	IG
cholesterol	IG
decrease-8	IG
is	O
not	O
associated	O
with	O
elevated	O
levels	O
of	O
LDL	BG
cholesterol-17	IG
(	O
r	O
=	O
-	O
0	O
.	O
20	O
,	O
NS	O
)	O
,	O
which	O
is	O
the	O
primary	O
characteristic	O
feature	O
of	O
familial	BP
hypercholesterolemia-37	IP
subjects	O
.	O

PS2989	O
Defects	O
in	O
the	O
ryanodine	BG
receptor-5	IG
(	O
RYR1-7	BG
)	O
gene	O
are	O
associated	O
with	O
malignant	BP
hyperthermia-14	IP
,	O
an	O
autosomal	O
dominant	O
disorder	O
of	O
skeletal	O
muscle	O
and	O
one	O
of	O
the	O
main	O
causes	O
of	O
death	O
resulting	O
from	O
anaesthesia-33	BP
.	O

PS3009	O
Mutations	O
in	O
the	O
high	O
penetrance	O
breast	O
and	O
ovarian	O
cancer	O
susceptibility	O
gene	O
BRCA1-12	BG
account	O
for	O
a	O
significant	O
percentage	O
of	O
hereditary	O
breast-20	BP
and	O
ovarian	BP
cancer-23	IP
cases	O
.	O

PS3033	O
Carbonic	O
anhydrase	O
II	O
deficiency	O
syndrome	O
characterized	O
by	O
osteopetrosis-8	BP
,	O
renal	BP
tubular	IP
acidosis-12	IP
,	O
and	O
cerebral	BP
calcifications-16	IP
is	O
caused	O
by	O
mutations	BG
in	IG
the	IG
carbonic	IG
anhydrase	IG
2-25	IG
gene	O
.	O

PS3041	O
The	O
association	O
of	O
the	O
rare	O
hereditary	BP
cancer	IP
syndrome	IP
,	O
multiple	BP
endocrine	IP
neoplasia	IP
type	IP
2a	IP
with	IP
Hirschsprung	IP
'	IP
s	IP
disease-19	IP
,	O
both	O
linked	O
to	O
germline	O
mutations	BG
in	IG
the	IG
RET	IG
proto	IG
-	IG
oncogene-31	IG
,	O
has	O
been	O
reported	O
recently	O
.	O

PS3047	O
In	O
conclusion	O
,	O
childhood	O
obesity-5	BP
contributes	O
to	O
higher	BG
plasminogen	IG
activator	IG
inhibitor	IG
-	IG
1-13	IG
and	O
tumor	BG
necrosis	IG
factor	IG
-	IG
alpha-19	IG
and	O
lower	BG
transforming	IG
growth	IG
factor	IG
beta-25	IG
levels	O
.	O

PS3050	O
Dyschromatosis	BP
symmetrica	IP
hereditaria	IP
is	O
an	O
autosomal	O
dominant	O
pigmentary	O
genodermatosis	O
characterized	O
by	O
hyperpigmented	O
and	O
hypopigmented	BP
macules-15	IP
of	O
on	O
the	O
extremities	O
and	O
caused	O
by	O
the	O
mutations	O
in	O
the	O
ADAR	BG
gene-28	IG
(	O
also	O
called	O
DSRAD-32	BG
)	O
encoding	O
for	O
RNA	BG
-	IG
specific	IG
adenosine	IG
deaminase-40	IG
.	O

PS3051	O
Heterozygous	O
germline	O
mutations	O
of	O
the	O
tumor	O
-	O
suppressor	O
gene	O
multiple	O
endocrine	BG
neoplasia	IG
type	IG
1-14	IG
are	O
responsible	O
for	O
multiple	O
endocrine	O
neoplasia-20	BP
type	O
1	O
,	O
a	O
dominantly	O
inherited	O
familial	O
cancer-28	BP
syndrome	O
characterized	O
by	O
pituitary	O
,	O
parathyroid	O
,	O
and	O
enteropancreatic	BP
tumors-38	IP
.	O

PS3100	O
In	O
conclusion	O
,	O
Angiotensin	BG
-	IG
converting	IG
enzyme-7	IG
activity	O
,	O
but	O
not	O
Angiotensin	BG
-	IG
converting	IG
enzyme-15	IG
polymorphisms	O
,	O
was	O
associated	O
with	O
the	O
degree	O
of	O
myocardial	BP
hypertrophy-25	IP
in	O
the	O
patients	O
with	O
hypertrophic	BP
cardiomyopathy-31	IP
.	O

PS3107	O
Activating	O
mutations	BG
of	IG
the	IG
p110	IG
alpha	IG
subunit	IG
of	IG
PI3K	IG
(	IG
PIK3CA	IG
)	IG
oncogene-13	IG
have	O
been	O
identified	O
in	O
a	O
broad	O
spectrum	O
of	O
malignant	BP
tumors-23	IP
.	O

PS3109	O
For	O
instance	O
,	O
mutations	O
of	O
the	O
gsp-7	BG
and	O
thyroid	BG
-	IG
stimulating	IG
hormone	IG
receptor	IG
genes-14	IG
are	O
associated	O
with	O
benign	O
hyperfunctioning	O
thyroid	O
nodules	O
and	O
adenomas	O
while	O
alterations	O
of	O
other	O
specific	O
genes	O
,	O
such	O
as	O
oncogenic	BG
tyrosine	IG
kinase-35	IG
alterations	O
(	O
RET-38	BG
/	O
PTC-40	BG
,	O
TRK-42	BG
)	O
in	O
papillary	BP
carcinoma-46	IP
and	O
the	O
newly	O
discovered	O
PAX8-51	BG
/	O
peroxisome	BG
proliferator	IG
-	IG
activated	IG
receptor	IG
gamma-58	IG
rearrangement	O
,	O
are	O
distinctive	O
features	O
of	O
cancer-65	BP
.	O

PS3179	O
Genetic	O
mutations	O
resulting	O
in	O
decreased	BG
neuronal	IG
Na	IG
(	IG
+	IG
)	IG
,	IG
K	IG
(	IG
+	IG
)	IG
-	IG
ATPase-17	IG
(	O
sodium	BG
-	IG
potassium	IG
adenosine	IG
triphosphatase-23	IG
)	O
activity	O
may	O
put	O
individuals	O
at	O
risk	O
for	O
depression-32	BP
given	O
that	O
decreased	BG
Na	IG
(	IG
+	IG
)	IG
,	IG
K	IG
(	IG
+	IG
)	IG
-	IG
ATPase-46	IG
activity	O
is	O
observed	O
in	O
depressive	BP
disorders-52	IP
and	O
animal	O
models	O
of	O
depression-57	BP
.	O

PS3205	O
FOXP1-1	BG
was	O
more	O
highly	O
expressed	O
in	O
familial	O
breast	BP
cancers-9	IP
compared	O
with	O
sporadic	BP
cancers-13	IP
for	O
luminal	O
(	O
p	O
=	O
0	O
.	O
021	O
)	O
and	O
basal	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
not	O
HER2-35	BG
and	O
null	O
phenotypes	O
(	O
both	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O

PS3221	O
Variants	O
in	O
HTRA1-3	BG
,	O
CFH-5	BG
,	O
and	O
C2-8	BG
were	O
also	O
associated	O
with	O
polypoidal	BP
choroidal	IP
vasculopathy-15	IP
.	O

PS3309	O
Malignant	BP
hyperthermia-2	IP
is	O
associated	O
,	O
in	O
the	O
majority	O
of	O
cases	O
,	O
with	O
mutations	BG
in	IG
RYR1-15	IG
,	O
the	O
gene	O
encoding	O
the	O
skeletal	BG
muscle	IG
ryanodine	IG
receptor-24	IG
.	O

PS3329	O
Parasitic	O
worm	O
infection	O
,	O
allergy	O
and	O
asthma-7	BP
involve	O
increased	O
IgE-10	BG
production	O
,	O
eosinophil	O
activity	O
,	O
mucus	O
secretion	O
and	O
smooth	O
muscle	O
reactivity	O
,	O
effected	O
through	O
Th	BG
-	IG
2-27	IG
immune	O
signalling	O
.	O

PS3609	O
In	O
addition	O
,	O
we	O
identified	O
several	O
CAPN10	BG
alleles-8	IG
associated	O
to	O
phenotypic	O
differences	O
observed	O
between	O
polycystic	BP
ovaries-16	IP
patients	O
,	O
such	O
as	O
the	O
presence	O
of	O
hypercholesterolemia-24	BP
(	O
haplotype	O
1121	O
,	O
P	O
=	O
0	O
.	O
005	O
)	O
,	O
presence	O
of	O
hyperandrogenic	O
features	O
(	O
P	O
=	O
0	O
.	O
05	O
)	O
,	O
and	O
familial	O
cancer-50	BP
incidence	O
(	O
haplotype	O
1111	O
,	O
P	O
=	O
0	O
.	O
0005	O
)	O
.	O

PS3405	O
Some	O
of	O
the	O
severe	O
(	O
the	O
majority	O
of	O
patients	O
affected	O
with	O
either	O
the	O
severe	O
form	O
)	O
spinal	BP
muscular	IP
atrophy-19	IP
cases	O
correlated	O
with	O
the	O
extent	O
of	O
deletions	O
in	O
the	O
SMN-29	BG
,	O
NAIP-31	BG
and	O
P44	BG
genes-34	IG
or	O
the	O
dosage	O
of	O
SMN	BG
gene-40	IG
when	O
both	O
SMN1-43	BG
and	O
SMN2-45	BG
are	O
deleted	O
.	O

PS3434	O
Mutations	BG
in	IG
the	IG
gene	IG
encoding	IG
filaggrin-6	IG
have	O
been	O
identified	O
as	O
the	O
cause	O
of	O
ichthyosis	BP
vulgaris-15	IP
and	O
have	O
been	O
shown	O
to	O
be	O
major	O
predisposing	O
factors	O
for	O
atopic	BP
eczema-27	IP
,	O
initially	O
in	O
European	O
populations	O
.	O

PS3449	O
Mucopolysaccharidosis	BP
type	IP
VI	IP
is	O
an	O
autosomal	O
recessive	O
lysosomal	O
storage	O
disease	O
caused	O
by	O
a	O
deficiency	BG
of	IG
N	IG
-	IG
acetylgalactosamine	IG
-	IG
4	IG
-	IG
sulphatase-22	IG
(	O
arylsulfatase	BG
B-25	IG
,	O
ASB-27	BG
)	O
.	O

PS3454	O
Mucopolysaccharidosis	BP
VI	IP
is	O
a	O
rare	O
autosomal	O
recessive	O
disorder	O
caused	O
by	O
a	O
deficiency	BG
of	IG
N	IG
-	IG
acetylgalactosamine	IG
-	IG
4	IG
-	IG
sulfatase-20	IG
(	O
ARSB-22	BG
)	O
.	O

PS3485	O
The	O
causative	O
gene	O
for	O
JPrimary	BP
lateral	IP
sclerosis-7	IP
was	O
found	O
to	O
be	O
ALS2-12	BG
,	O
which	O
is	O
also	O
responsible	O
for	O
a	O
recessive	O
form	O
of	O
amyotrophic	BP
lateral	IP
sclerosis-25	IP
,	O
for	O
infantile	O
onset	O
ascending	O
hereditary	O
spastic	BP
paralysis-33	IP
and	O
for	O
a	O
form	O
of	O
complicated	O
hereditary	O
spastic	BP
paraplegia-42	IP
.	O

PS3573	O
Interleukin	BG
-	IG
6-3	IG
,	O
an	O
inflammatory	O
cytokine	O
,	O
is	O
thought	O
to	O
play	O
a	O
role	O
in	O
neurodegeneration	O
of	O
the	O
central	O
nervous	O
system	O
and	O
has	O
been	O
associated	O
with	O
increased	O
amyloid	BG
precursor	IG
protein-30	IG
expression	O
in	O
vitro	O
and	O
greater	O
cognitive	BP
decline-37	IP
.	O

PS3585	O
Mutations	BG
in	IG
the	IG
skeletal	IG
muscle	IG
alpha	IG
-	IG
actin	IG
gene-9	IG
(	O
ACTA1-11	BG
)	O
associated	O
with	O
congenital	BP
myopathy-16	IP
with	O
excess	O
of	O
thin	O
myofilaments	O
,	O
nemaline	BP
myopathy-24	IP
and	O
intranuclear	BP
rod	IP
myopathy-28	IP
were	O
first	O
described	O
in	O
1999	O
.	O
